Body Mass Index and Treatment Response in Patients with Cardiac Light-Chain Amyloidosis

Abstract

Light-chain amyloidosis (AL) is a clonal plasma cell disorder in which monoclonal light chains form fibrils that deposit in the tissues of vital organs. Incidence and prevalence are low and has been estimated to range from 3-12 cases per million persons/year and 30,000-45,000 patients in the United States and European Union, respectively [11].Approximately half of AL amyloidosis patients present with cardiac involvement which impacts survival [12-